CD8A and neoplasm: Chen and colleagues have also found that PD-L1 on metastatic melanoma-derived exosomes inhibits the activation of CD8+ T cells and facilitates tumor growth, and these effects can be disrupted by anti-PD-1 antibody (aPD-1) therapy [16].